AMEX · Financial Statements

MAIA Biotechnology, Inc. (MAIA) Revenue, Earnings & Financial Statements

$1.25 AMEX: MAIA Market Cap $77.19M

Data as of Nov 17, 2026 close · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)

MAIA Biotechnology, Inc. most recently reported annual revenue of $0, a net loss of $22.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

MAIA Biotechnology, Inc.: net profit was positive in 0 of 7 reported years; the most recent year shows a net loss of $22.0M.

Income Statement — 7 Years (USD millions)

Metric2019202020212022202320242025
Revenue$0$0$0$0$0$0$0
Operating Expenses$7.0M$7.0M$8.0M$16.0M$20.0M$17.0M$24.0M
Operating Profit−$7.0M−$7.0M−$8.0M−$16.0M−$20.0M−$17.0M−$24.0M
Other Income$0$0−$5.0M$0$0−$6.0M$2.0M
Interest$0$0$1.0M$0$0$0$0
Depreciation$7.0M$7.0M$0$0$0$0$0
Profit Before Tax−$7.0M−$7.0M−$13.0M−$16.0M−$20.0M−$23.0M−$22.0M
Tax rate (%)0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net Profit−$6.0M−$7.0M−$13.0M−$16.0M−$20.0M−$23.0M−$22.0M
EPS−$0.61−$0.62−$1.18−$1.70−$1.49−$1.05−$0.70

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricDec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26
Revenue$0$0$0$0$0$0$0$0$0$0$0$0
Operating Expenses$6.0M$4.0M$4.0M$4.0M$5.0M$5.0M$5.0M$9.0M$4.0M$7.0M$8.0M$8.0M
Operating Profit−$6.0M−$4.0M−$4.0M−$4.0M−$5.0M−$5.0M−$5.0M−$9.0M−$4.0M−$7.0M−$8.0M−$8.0M
Interest$0$0$0$0$0$0$0$0$0$0$0$0
Profit Before Tax−$6.0M−$8.0M−$9.0M−$3.0M−$4.0M−$5.0M−$5.0M−$9.0M−$4.0M−$6.0M−$8.0M−$7.0M
Tax rate (%)0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%-4.9%0.0%
Net Profit−$6.0M−$8.0M−$9.0M−$3.0M−$4.0M−$5.0M−$5.0M−$9.0M−$4.0M−$6.0M−$8.0M−$7.0M
EPS−$0.37−$0.46−$0.40−$0.11−$0.14−$0.16−$0.18−$0.27−$0.09−$0.14−$0.13−$0.12

Over the 7 years reported for MAIA Biotechnology, Inc., cash stood at $8.7B in the latest year, shareholders' equity was $0, current assets covered current liabilities 1.67 times.

Balance Sheet — 7 Years (USD millions)

Metric2019202020212022202320242025
Total Assets$2.0M$1.0M$11.0M$12.0M$8.0M$10.0M$10.0M
Current Assets$2.0M$1.0M$11.0M$12.0M$8.0M$10.0M$10.0M
Cash$2.0M$1.0M$11.0M$11.0M$7.0M$10.0M$8.7B
Inventory$0$0$0$0$0$0$0
Receivables$0$0$0$0$0$0$0
Fixed Assets$0$0$0$0$0$0$0
Capital Work in Progress$0$0$0$0$0$0$0
Investments$0$0$0$0$0$0$0
Other Assets$0$0$0$0$0$0$0
Total Liabilities$0$2.0M$2.0M$4.0M$7.0M$7.0M$7.0M
Current Liabilities$0$2.0M$2.0M$3.0M$5.0M$4.0M$6.0M
Borrowings$0$0$0$0$0$0$0
Other Liabilities$0$2.0M$2.0M$4.0M$7.0M$7.0M$7.0M
Equity$0$0$0$0$0$0$0
Reserves$0−$3.0M$9.0M$9.0M$0$4.0M$2.0M

For MAIA Biotechnology, Inc., operating cash flow was positive in 0 of 7 reported years; free cash flow in the latest year was negative at $19.0M; free cash flow was positive in 0 of 7 years; financing activities used $1.0M in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 7 Years (USD millions)

Metric2019202020212022202320242025
Operating Cash Flow−$2.0M−$2.0M−$4.0M−$12.0M−$13.0M−$16.0M−$19.0M
Investing Cash Flow$0$0$0$0$0$0$0
Financing Cash Flow$0$0$1.0M−$1.0M−$2.0M−$1.0M−$1.0M
Net Cash Flow$2.0M−$1.0M$10.0M$0−$4.0M$2.0M−$1.0M
Free Cash Flow−$2.0M−$2.0M−$4.0M−$12.0M−$13.0M−$16.0M−$19.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.05
EV / EBITDA-1.63
FCF Yield-41.12%
Quick Ratio3.41
Interest Coverage—
Return 1Y25.00%
Return 3Y3.31%
Return 5Y—

MAIA Biotechnology, Inc. (MAIA) financials — frequently asked questions

What is MAIA Biotechnology, Inc.'s annual revenue?

MAIA Biotechnology, Inc. (MAIA) reported annual revenue of $0 in its most recent fiscal year.

What is MAIA Biotechnology, Inc.'s net profit?

MAIA Biotechnology, Inc. (MAIA) reported a net loss of $22.0M in its most recent fiscal year.

What is MAIA EV/EBITDA?

MAIA Biotechnology, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -1.63. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.

Revenue and earnings of other Biotechnology stocks

VRTX revenue $12.1BREGN revenue $14.3BMRNA revenue $1.9BRVMD financialsROIV revenue $8.0MINSM revenue $606.0MUTHR revenue $3.2BINCY revenue $5.1BALNY revenue $3.7BASND revenue $692.0MAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
MAIA Overview MAIA Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.